{"id":"https://openalex.org/W4391884481","doi":"https://doi.org/10.1158/2767-9764.c.7078148","title":"Data from Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3\u03b2 Activation and c-Myc and Mcl-1 Proteasomal Degradation","display_name":"Data from Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3\u03b2 Activation and c-Myc and Mcl-1 Proteasomal Degradation","publication_year":2024,"publication_date":"2024-02-16","ids":{"openalex":"https://openalex.org/W4391884481","doi":"https://doi.org/10.1158/2767-9764.c.7078148"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.c.7078148","doi":"https://doi.org/10.1158/2767-9764.c.7078148","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.7078148","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2767-9764.c.7078148","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026057477","display_name":"Jonelle K. Lee","orcid":"https://orcid.org/0000-0001-7250-6818","observed_orcids":["https://orcid.org/0000-0001-7250-6818"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonelle K. Lee","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7250-6818","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040265273","display_name":"Aditi Chatterjee","orcid":"https://orcid.org/0000-0003-0595-3866","observed_orcids":["https://orcid.org/0000-0003-0595-3866"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aditi Chatterjee","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0595-3866","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082280429","display_name":"Mario Scarpa","orcid":"https://orcid.org/0000-0001-6885-6778","observed_orcids":["https://orcid.org/0000-0001-6885-6778"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mario Scarpa","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6885-6778","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029789482","display_name":"Christopher M. Bailey","orcid":"https://orcid.org/0000-0002-2259-0502","observed_orcids":["https://orcid.org/0000-0002-2259-0502"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher M. Bailey","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2259-0502","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054706220","display_name":"Sandrine Niyongere","orcid":"https://orcid.org/0000-0001-9254-0095","observed_orcids":["https://orcid.org/0000-0001-9254-0095"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandrine Niyongere","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9254-0095","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084575052","display_name":"Prerna Singh","orcid":"https://orcid.org/0000-0002-7808-6049","observed_orcids":["https://orcid.org/0000-0002-7808-6049"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Prerna Singh","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7808-6049","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020357166","display_name":"Moaath K. Mustafa Ali","orcid":"https://orcid.org/0000-0003-3289-2333","observed_orcids":["https://orcid.org/0000-0003-3289-2333"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Moaath K. Mustafa Ali","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3289-2333","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064415728","display_name":"Shivani Kapoor","orcid":"https://orcid.org/0009-0003-6060-6637","observed_orcids":["https://orcid.org/0009-0003-6060-6637"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shivani Kapoor","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-6060-6637","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027415109","display_name":"Yin Wang","orcid":"https://orcid.org/0000-0002-4749-3768","observed_orcids":["https://orcid.org/0000-0002-4749-3768"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yin Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4749-3768","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056803476","display_name":"Giovannino Silvestri","orcid":"https://orcid.org/0000-0001-5911-6997","observed_orcids":["https://orcid.org/0000-0001-5911-6997"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giovannino Silvestri","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5911-6997","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5049910941","display_name":"Maria R. Baer","orcid":"https://orcid.org/0000-0002-9499-1348","observed_orcids":["https://orcid.org/0000-0002-9499-1348"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria R. Baer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9499-1348","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12582","display_name":"Flavonoids in Medical Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/flt3-itd-acute-myeloid-leukemia","display_name":"FLT3-ITD acute myeloid leukemia","score":0.949999988079071},{"id":"https://openalex.org/keywords/gilteritinib","display_name":"gilteritinib","score":0.9470000267028809},{"id":"https://openalex.org/keywords/pim-kinase-inhibitors","display_name":"PIM kinase inhibitors","score":0.9869999885559082},{"id":"https://openalex.org/keywords/azd1208","display_name":"AZD1208","score":0.9490000009536743},{"id":"https://openalex.org/keywords/c-myc-phosphorylation","display_name":"c-Myc phosphorylation","score":0.9010000228881836},{"id":"https://openalex.org/keywords/mcl-1-phosphorylation","display_name":"Mcl-1 phosphorylation","score":0.9959999918937683},{"id":"https://openalex.org/keywords/proteasomal-degradation","display_name":"proteasomal degradation","score":0.8560000061988831},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.718999981880188},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6940000057220459},{"id":"https://openalex.org/keywords/flt3-inhibitors","display_name":"FLT3 inhibitors","score":0.7070000171661377},{"id":"https://openalex.org/keywords/stat5-signaling","display_name":"STAT5 signaling","score":0.7139999866485596},{"id":"https://openalex.org/keywords/synergistic-cytotoxicity","display_name":"synergistic cytotoxicity","score":0.7400000095367432}],"concepts":[{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.768675684928894},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.6570849418640137},{"id":"https://openalex.org/C2779679103","wikidata":"https://www.wikidata.org/wiki/Q5251805","display_name":"Degradation (telecommunications)","level":2,"score":0.6021945476531982},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5878123044967651},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5089161396026611},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4281589090824127},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.42348945140838623},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19753634929656982},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18316903710365295},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1781739592552185},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.16352787613868713},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.09609949588775635},{"id":"https://openalex.org/C76155785","wikidata":"https://www.wikidata.org/wiki/Q418","display_name":"Telecommunications","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2767-9764.c.7078148","doi":"https://doi.org/10.1158/2767-9764.c.7078148","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.7078148","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.c.7078148","doi":"https://doi.org/10.1158/2767-9764.c.7078148","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.7078148","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4391313605","https://openalex.org/W4282920721","https://openalex.org/W4391884497","https://openalex.org/W3212770966","https://openalex.org/W4391879140","https://openalex.org/W2954825813","https://openalex.org/W4391879141","https://openalex.org/W4361945573","https://openalex.org/W2887253947","https://openalex.org/W2767156284"],"abstract_inverted_index":{"Abstract":[0],"Acute":[1],"myeloid":[2],"leukemia":[3],"(AML)":[4],"with":[5,41,52,99,160,187,217,259,267,315],"fms-like":[6],"tyrosine":[7],"kinase":[8,32,196,265],"3":[9],"internal":[10],"tandem":[11],"duplication":[12],"(FLT3-ITD)":[13],"has":[14],"poor":[15,261],"outcomes.":[16,262],"FLT3-ITD":[17,248,251,300],"drives":[18],"constitutive":[19],"and":[20,26,43,54,83,86,94,113,140,143,152,189,201,206,209,220,234,277,286,290,302],"aberrant":[21],"FLT3":[22,34,55,101,270],"signaling,":[23],"activating":[24],"STAT5":[25],"upregulating":[27],"the":[28,72,100,105,194,228,268,311],"downstream":[29],"oncogenic":[30],"serine/threonine":[31,195],"Pim-1.":[33],"inhibitors":[35,56,107,191,266],"are":[36,215],"in":[37,60,90,146,148,247,254,257,275,278,299],"clinical":[38,308],"use,":[39],"but":[40],"limited":[42],"transient":[44],"efficacy.":[45],"We":[46],"previously":[47],"showed":[48],"that":[49],"concurrent":[50,185],"treatment":[51,186],"Pim":[53,106,111,153,190,235,264,312],"increases":[57,273],"apoptosis":[58,82,117,182,211],"induction":[59],"FLT3-ITD\u2013expressing":[61,91],"cells":[62,158],"through":[63,280],"posttranslational":[64],"downregulation":[65,208],"of":[66,74,76,131,156,230,232,256,282,296,306],"Mcl-1.":[67,291],"Here":[68],"we":[69],"further":[70,239],"elucidate":[71],"mechanism":[73,229],"action":[75,231],"this":[77],"dual":[78],"targeting":[79],"strategy.":[80],"Cytotoxicity,":[81],"protein":[84,124],"expression":[85],"turnover":[87,130,179],"were":[88],"measured":[89],"cell":[92],"lines":[93],"AML":[95],"patient":[96],"blasts":[97],"treated":[98],"inhibitor":[102,112,154,236,271,313],"gilteritinib":[103,114,188,233,272],"and/or":[104],"AZD1208":[108],"or":[109,163,180],"TP-3654.":[110],"cotreatment":[115,155],"increased":[116,129,141],"induction,":[118],"produced":[119],"synergistic":[120],"cytotoxicity,":[121],"downregulated":[122],"c-Myc":[123,162,205,218,289],"expression,":[125],"earlier":[126],"than":[127],"Mcl-1,":[128],"both":[132],"proteins,":[133,176],"which":[134,284],"was":[135],"rescued":[136],"by":[137,224],"proteasome":[138],"inhibition,":[139],"efficacy":[142,295],"prolonged":[144],"survival":[145],"an":[147],"vivo":[149,279],"model.":[150],"Gilteritinib":[151],"Ba/F3-ITD":[157],"infected":[159],"T58A":[161],"S159A":[164],"Mcl-1":[165,207,221],"plasmids,":[166],"preventing":[167],"phosphorylation":[168,223],"at":[169],"these":[170,175],"sites,":[171],"did":[172],"not":[173],"downregulate":[174],"increase":[177,181],"their":[178],"induction.":[183,212],"Moreover,":[184],"dephosphorylated":[192],"(activated)":[193],"glycogen":[197],"synthase":[198],"kinase-3\u03b2":[199],"(GSK-3\u03b2),":[200],"GSK-3\u03b2":[202,226,241,297],"inhibition":[203],"prevented":[204],"decreased":[210],"The":[213,292],"data":[214,293],"consistent":[216],"T58":[219],"S159":[222],"activated":[225],"as":[227,243],"combination":[237],"treatment,":[238],"supporting":[240],"activation":[242,281,298],"a":[244,307],"therapeutic":[245],"strategy":[246],"AML.":[249],"Significance:":[250],"is":[252],"present":[253],"25%":[255],"AML,":[258,301],"continued":[260],"Combining":[263],"FDA-approved":[269],"cytotoxicity":[274],"vitro":[276],"GSK-3\u03b2,":[283],"phosphorylates":[285],"posttranslationally":[287],"downregulates":[288],"support":[294,304],"also":[303],"development":[305],"trial":[309],"combining":[310],"TP-3654":[314],"gilteritinib.":[316]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-02-17T00:00:00"}